The FDA Approves Oral Antiviral Treatment for COVID-19

The Food and Drug Administration (FDA) approved the oral antiviral Paxlovid for the treatment of mild to moderate COVID-19 in adults who are at high risk for progression to severe COVID-19 on May 25. Paxlovid packaged under the emergency use authorization (EUA) will continue to be available to ensure access for adults and treatment of eligible children ages 12-18 who are not covered under new FDA approval. Because of the importance of reducing the risk of significant drug-drug interactions with Paxlovid, the approved label and authorized Fact Fact Sheet for Health Care Providers for the Paxlovid EUA come with a boxed warning with instructions for prescribers. Prescribers should review all patient medications prior to prescribing.

The post The FDA Approves Oral Antiviral Treatment for COVID-19 appeared first on Pennsylvania Office of Rural Health.

Related Articles

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

What Are the Risk and Protective Factors for Violent Child Death?

Gun violence and traffic crashes may seem like unpredictable events. But they are not random. They are systematic. Data reveal trends and patterns in gun violence and traffic crashes that can help us identify risk factors and protective factors. This is especially important for addressing violent child deaths. So what does the data show? Join …
The post What Are the Risk and Protective Factors for Violent Child Death? appeared first on Salud America.

FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision

The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.

As Social Need Screening Advances, Transportation Remains an Afterthought

Some big changes in 2022 and 2023 have set up the healthcare sector to advance screening for non-medical social needs in 2024 and beyond. This is great news as we work to address social determinants of health (SDoH), improve health outcomes, and reduce health disparities. But one key social need – transportation – isn’t getting …
The post As Social Need Screening Advances, Transportation Remains an Afterthought appeared first on Salud America.

What Latino Parents Should Know: COVID-19 Vaccinations Authorized for Children Under 5

Big news for Latino parents – the Moderna and the Pfizer-BioNTech COVID-19 vaccines have been authorized for children between ages 6 months and 5 years. The CDC now recommends everyone 6 months or older to get vaccinated against COVID-19. Those 5 years of age and older are also recommended to get a COVID-19 vaccine booster, …
The post What Latino Parents Should Know: COVID-19 Vaccinations Authorized for Children Under 5 appeared first on Salud America.